Skye Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-2.9M | $64.8K |
| FY2017 | — | $-3.6M | $260.0K |
| FY2018 | — | $-15.6M | $1.9M |
| FY2019 | — | $548.1K | $1.8M |
| FY2020 | — | $450.8K | $2.5M |
| FY2021 | — | $5.9M | $9.0M |
| FY2022 | — | $-3.0M | $1.2M |
| FY2023 | — | $-2.1M | $1.3M |
| FY2024 | — | $68.2M | $68.4M |
| FY2025 | — | $20.0M | $5.9M |